Early Goal Directed Therapy in Sepsis by Emergency Medical Services
NCT ID: NCT02266654
Last Updated: 2017-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-10-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators think that the best thing to do for septic patients is to identify and treat them as early as possible. This research will test this. The investigators think that if paramedics identify septic patients and begin treatment with fluids in the ambulance, then the patient will do better in the long run. The paramedic will also tell the hospital that a septic patient will be there soon. The caregivers can prepare and be ready to provide care as soon as the patient arrives. With this research, the investigators would like to see if these steps help patient outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery
NCT01654003
Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain
NCT02706379
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721
CLEAR Sepsis Clinical Study
NCT03231956
Sepsis Trial of Early Physical Therapy Outside the ICU
NCT02159222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prehospital-directed therapy arm
Patients who are hypotensive or whose lactate is ≥ 2.5, prehospital providers will provide a notification to the receiving hospital (Hospital Notification), establish an IV, and provide 1 liter normal saline (NS) bolus of IV fluids. An additional 1 liter normal saline bolus will be given for systolic blood pressure less than 100. Patients who have a history of end-stage renal disease or congestive heart failure would receive only 20 milliliters/kilogram of fluid. If the patient remains hypotensive, Emergency Medical Services will continue providing fluids as is standard of care.
IV fluids
Normal Saline 0.9%
Hospital Notification
Prehospital providers will notify the receiving hospital over the radio or telephone that they are transporting a patient who meets Sepsis Criteria
Control Arm
Prehospital providers will obtain a point of care lactate, establish an IV, and provide IV fluids as judged necessary.
IV fluids
Normal Saline 0.9%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IV fluids
Normal Saline 0.9%
Hospital Notification
Prehospital providers will notify the receiving hospital over the radio or telephone that they are transporting a patient who meets Sepsis Criteria
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspected to having an infection
* Meets 2 of 3 systemic inflammatory response criteria: heart rate \> 90 beats per minute, respiratory rate \>20 breaths per minute, temperature \>38°C or \<36°C
Exclusion Criteria
* Patients, coming from a rehabilitation/nursing facility where antibiotics were given prior to transfer
* Pregnant patients
* Prisoners.
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pro EMS
UNKNOWN
Mount Auburn Hospital
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Filbin, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Filbin, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
William Porcaro, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Mount Auburn Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Auburn Hospital
Cambridge, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
019-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.